Skip to content

Gastroparesis Reference

Gastroparesis is a gastrointestinal motility disorder in which solid food leaves the stomach abnormally slowly despite the absence of a mechanical blockage. Diagnosis requires both compatible symptoms and objective evidence of delayed emptying; nausea, vomiting, fullness, or abdominal pain alone do not establish it.

Overview and Terminology

The stomach normally stores a meal, grinds solid food into smaller particles, and coordinates its release into the small intestine. Gastroparesis can involve abnormalities in smooth muscle, enteric nerves, vagal signaling, interstitial cells of Cajal, pyloric function, or several mechanisms at once. It is therefore not accurately described as the vagus nerve simply stopping in every patient.

‘’Delayed gastric emptying’’ can describe a test result or physiological finding. ‘’Gastroparesis’’ describes the clinical disorder when delayed emptying occurs with compatible symptoms and no obstruction. ‘’Gastric stasis’’ is an older or descriptive term and does not by itself identify a cause.

‘’Feed rejection’’ is not a formal gastroparesis diagnosis. Charlie and people close to him used the phrase for episodes of severe tube-feed intolerance with nausea or vomiting. The shorthand described what the episode felt like and how the household responded; it did not mean that the feeding tube itself had mechanically rejected formula or establish one cause for every episode.

Causes and Associated Factors

Many cases are idiopathic, meaning that no single underlying cause is identified. Diabetes is the most common known cause in the United States and can affect gastric nerves, muscle, and pacemaker cells. Acute hyperglycemia can also slow emptying and complicate both testing and symptom management.

Postsurgical gastroparesis most clearly follows operations involving the stomach, esophagus, or proximal small intestine when vagal or gastric structures are injured. Neurological disease, hypothyroidism, scleroderma and some other systemic or autoimmune disorders, and some viral illnesses can also be associated with persistent delayed emptying.

Critical illness, sepsis, surgery, opioids, sedatives, metabolic disturbance, and hemodynamic instability can produce acute gastric dysmotility and feeding intolerance. Acute delay during an intensive-care admission does not automatically establish permanent gastroparesis; persistent symptoms require evaluation after the immediate illness and medication effects are considered.

Opioids, anticholinergic medicines, some antidepressants, and other medications can delay gastric emptying or worsen a person’s existing symptoms. A medication review is part of assessment, but a clinically necessary drug is not stopped without an individualized risk-and-benefit decision.

Gastrointestinal symptoms and abnormal motility can occur among people with POTS, hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorders, and mast-cell disease. The observed overlap does not establish a universal syndrome or one shared cause. Each diagnosis still requires its own criteria and relevant testing.

Symptoms and Presentation

Common symptoms include nausea, early satiety, prolonged fullness after eating, vomiting, bloating, upper-abdominal discomfort or pain, reflux, poor appetite, and difficulty taking enough food or fluid. Some people vomit frequently; others have little or no vomiting and are affected more by fullness, pain, or nutritional limitation.

Symptoms may worsen after meals, fluctuate across days or longer periods, and interact with migraine, vestibular illness, infection, pain, stress, sleep disruption, medication, and blood-glucose changes. Those interactions do not make the symptoms psychological or identify gastroparesis as the cause of every vomiting episode.

The measured degree of delayed emptying does not consistently predict symptom severity. A person with a modest delay can be profoundly symptomatic, while a person with greater retention can report less distress. Clinical care therefore considers symptoms, nutritional effects, hydration, coexisting conditions, and function rather than treating a scan percentage as a complete severity score.

Vomiting can include food eaten hours earlier, but that feature is neither required nor unique to gastroparesis. Projectile vomiting is not a defining characteristic. New forceful vomiting, blood, severe or localized pain, fever, fainting, breathing difficulty, or prolonged inability to retain fluid requires assessment for obstruction, bleeding, infection, metabolic disturbance, aspiration, or another acute problem rather than automatic attribution to a familiar diagnosis.

Diagnosis and Differential Diagnosis

Evaluation begins with medical history, medication and substance review, physical examination, nutritional and hydration assessment, and testing guided by the presentation. Upper endoscopy or imaging is used when needed to exclude gastric-outlet or intestinal obstruction and other structural disease. Retained food seen during endoscopy can raise suspicion but does not diagnose gastroparesis by itself.

Four-hour solid-meal gastric emptying scintigraphy is the principal standardized test. The 2025 American Gastroenterological Association guideline recommended four-hour testing rather than a study lasting two hours or less because shorter protocols can miss delayed emptying. The meal, image timing, glucose management, and temporary holding of medications that alter motility follow the testing center’s protocol and the patient’s clinical needs.

A validated carbon-13 gastric emptying breath test can provide an alternative in some settings. Wireless motility capsule testing can assess transit beyond the stomach when broader dysmotility is relevant, although it does not measure digestion of a meal in the same way as scintigraphy. Test results are interpreted alongside symptoms and the conditions under which the test occurred.

The differential diagnosis includes mechanical obstruction, peptic or inflammatory disease, functional dyspepsia, chronic nausea and vomiting syndromes, cyclic vomiting syndrome, rumination syndrome, cannabinoid hyperemesis, eating disorders, migraine-associated vomiting, medication effects, endocrine or metabolic disease, and rapid rather than delayed gastric emptying. Several of these conditions can coexist. A previous gastroparesis diagnosis does not remove the need to evaluate a new or substantially changed pattern.

Treatment and Nutritional Support

Treatment is individualized around the cause, dominant symptoms, nutrition, hydration, coexisting illness, and the person’s priorities. In diabetic gastroparesis, glucose management is part of care. Medication that worsens emptying is reviewed when clinically feasible, and a dietitian familiar with gastrointestinal motility disorders can help prevent both malnutrition and unnecessary restriction.

Small-particle and lower-fat food is often better tolerated than large pieces or high-fat solid meals. Smaller portions, softer or blended food, and liquid nutrition can help some people. Fiber content, meal timing, oral hydration, and the balance between solid and liquid intake are adjusted to the individual; there is no universal list of safe and forbidden foods.

When oral intake is inadequate, enteral nutrition delivered beyond the stomach can support nutrition while using the gastrointestinal tract. Jejunal access may be temporary or long-term. Parenteral nutrition is generally reserved for situations in which oral and enteral routes cannot meet the person’s needs. Tube route, formula, delivery schedule, venting, hydration, and oral intake remain separate individualized decisions.

Metoclopramide can improve symptoms and gastric emptying and is the only medication specifically approved by the United States Food and Drug Administration for diabetic gastroparesis. Its prescribing information carries a boxed warning for tardive dyskinesia and generally advises avoiding treatment longer than twelve weeks except when the expected benefit justifies the risk. Monitoring accounts for neurological adverse effects and the person’s other medications and conditions.

Erythromycin can accelerate emptying, but benefit often diminishes with continued use, so it is commonly used for shorter periods. Antiemetics such as ondansetron, promethazine, or prochlorperazine can reduce nausea and vomiting but do not improve gastric emptying. Domperidone is not approved or legally marketed for human use in the United States; access has depended on an expanded-access investigational program, and the previous program’s supply ended in 2025. Availability and regulatory status differ by country and time.

Pyloric procedures, gastric electrical stimulation, and surgical interventions are considered only after reassessment of the diagnosis, nutrition, medication trials, goals, and alternatives. The 2025 AGA guideline recommended against routine botulinum-toxin injection, gastric peroral endoscopic pyloromyotomy, or gastric electrical stimulation for all medically refractory patients because the evidence did not support automatic use. An intervention can still be considered for a carefully selected person through shared decision-making rather than treated as the next universal step.

Course, Complications, and Daily Access

Gastroparesis can remain chronic, fluctuate, improve after treatment of a reversible cause, or change enough to require repeat assessment. It is not universally progressive. Complications can include dehydration, electrolyte imbalance, weight loss, malnutrition, vitamin or mineral deficiency, aspiration, bezoars, and unstable blood glucose in people with diabetes.

Tube feeding does not guarantee the end of nausea or vomiting. Intolerance can reflect the underlying motility disorder, route, formula, delivery rate, tube position, infection, medication, constipation, migraine, vestibular symptoms, mast-cell symptoms, or another illness. Persistent or severe intolerance prompts reassessment rather than one fixed home protocol.

Daily access can include flexible meal or feeding schedules, bathroom and cleanup access, breaks after eating, permission to carry medication and nutrition supplies, refrigeration or storage, seating or reclining options, remote participation during severe flares, and protection from punishment for vomiting or interrupted attendance. Not every person needs the same accommodation.

Vomiting, weight change, restricted intake, and normal test results from an incomplete study can all attract dismissal or stigma. Symptoms may be mislabeled as anxiety or an eating disorder, while an actual eating disorder can also be missed if clinicians assume gastroparesis explains every change in intake. Accurate care takes both possibilities seriously and investigates rather than moralizing.

Associated Characters

Charlie Rivera

Main article: Charlie Rivera (Progressive Disability Journey)

Charlie experienced recurrent nausea, vomiting, dehydration, and inability to maintain adequate nutrition from childhood. Acute care repeatedly stabilized the immediate consequences without identifying the larger pattern. During his two-week Mount Sinai hospitalization in late 2027, at age twenty, a gastric emptying study confirmed gastroparesis alongside formal POTS evaluation.

The gastroparesis later interacted with, but was not interchangeable with, Charlie’s chronic migraine, vestibular dysfunction, POTS, ME/CFS, hEDS, and later mast cell activation syndrome. Motion, migraine, autonomic flares, and formula intolerance could compound nausea without proving that gastroparesis caused every episode.

At twenty-five, in late 2032 or early 2033, worsening vomiting, weight loss, weakness, and nutritional instability led to placement of a long-term GJ tube. The crisis included a rehearsal in which he vomited repeatedly and nearly fainted before Ezra Cruz stopped the session, followed by the bathroom-floor moment when Charlie begged Logan Weston, “Don’t let me die.” Logan called Dr. Meyers, and Julia Weston helped both men through the transition. The tube initially supplemented oral intake and had become Charlie’s primary nutrition source by age thirty-three, with very occasional oral intake continuing as tolerated.

Charlie and Logan called the later episodes of severe tube-feed intolerance and vomiting ‘’feed rejection’‘. Logan learned Charlie’s individual warning signs and how to pause the feed and follow his established care plan, but the episodes were not entirely predictable. On one deliberate livestream during an already difficult health day, Charlie experienced feed intolerance and vomited on camera before ending the stream; the episode became part of his refusal to conceal the ordinary physical realities of disabled life.

During the 2038 Puerto Rico trip, vomiting during the drive to JFK and persistent motion sickness continued into the airport. Charlie signaled when he could no longer tolerate a slow gate-side tube feed; Logan stopped the pump and flushed the line before Riley held an emesis bag and Elliot shielded Charlie from the surrounding crowd. Turbulence and landing later provoked further nausea, dry heaving, and vomiting.

Other documented episodes included the 2043 “Feed Rejection Rehearsal” at Rising Notes Camp Campus and the medical crisis underway during the 2044 traffic stop. By Charlie’s early seventies, severe episodes occurred roughly once or twice weekly during difficult periods and could trigger wider POTS crashes. They became more severe during his final years and contributed to the increasing limits on touring and live performance.

Andy Davis

Main article: Andy Davis

Andy had gastroparesis alongside spastic diplegic cerebral palsy, epilepsy, autism, sleep apnea, and other disabilities. Gastroparesis remained a distinct diagnosis rather than a generic label for all of his gastrointestinal symptoms, and his care addressed it within his broader support needs.

Minjae Lee

Main article: Minjae Lee

Minjae had gastroparesis alongside POTS, cerebral palsy, Lennox–Gastaut syndrome, autism, global developmental delay, and severe chronic fatigue. He used long-term feeding-tube access for supplemental nutrition when gastroparesis, fatigue, illness, or a post-viral crash made oral intake inadequate. Tube feeding was not his sole nutrition source.

Charlie became an older-brother and mentor figure partly because the two shared POTS, gastroparesis, and tube-feeding experience. Seeing Charlie use a portable pump as an ordinary part of daily life made the equipment more familiar to Minjae without eliminating Minjae’s own preferences or ordinary objections when he was exhausted.

Connor Martinez

Main article: Connor Martinez Appendicitis and Septic Crisis (Thanksgiving 1998) - Event

Connor developed permanent mild-to-moderate gastroparesis after the perforated-appendix and septic-shock crisis that began on Thanksgiving 1998. His lasting disorder resulted from severe inflammation and infection in his abdominal cavity, combined with prolonged hypotension that damaged the nerves regulating his digestion. His continuing presentation included chronic nausea, early satiety, and variable food tolerance. His care did not require tube feeding.

He ate six to eight small meals a day and adjusted portions and composition to his current tolerance. His customary options included plain toast, crackers, white rice, applesauce, bananas, well-cooked potatoes without the skin, small amounts of chicken breast, scrambled or boiled eggs, nutrition shakes, smoothies, broth-based soups, and pasta with light sauce. He drank ginger tea frequently. These were foods he often managed, not a guarantee that the same food would be tolerable every day.

Connor used anti-nausea medication as needed and took scheduled prokinetic medication to help gastric emptying. The prokinetics had limited benefit and possible side effects. He carried medication and snacks, attended regular gastroenterology appointments, and fitted eating around school and activity. Large portions, high-fat or high-fiber foods, and spicy dishes could trigger symptoms; PE required a very small meal about an hour beforehand and more food afterward to balance nausea against weakness and dizziness.

Sources

Medical Conditions Gastrointestinal Conditions Chronic Conditions